Bacterial diseases caused by Vibrio spp. are prevalent in aquaculture and can lead to high mortality rates among aquatic species and significant economic losses. With the increasing emergence of multidrug-resistant Vibrio strains, phage therapy is being explored as a potential alternative to antibiotics for biocontrol of infectious diseases. Here, a new lytic phage named vB_VhaS_R21Y (R21Y) was isolated against Vibrio harveyi BVH1 obtained from seawater from a scallop-farming area in Rongcheng, China. Its morphology, infection cycle, lytic profile, phage stability, and genetic features were characterized. Transmission electronic microscopy indicated that R21Y is siphovirus-like, comprising an icosahedral head (diameter 73.31 ± 2.09 nm) and long noncontractile tail (205.55 ± 0.75 nm). In a one-step growth experiment, R21Y had a 40-min latent period and a burst size of 35 phage particles per infected cell. R21Y was highly species-specific in the host range test and was relatively stable at pH 4-10 and 4-55 °C. Genomic analysis showed that R21Y is a double-stranded DNA virus with a genome size of 82,795 bp and GC content of 47.48%. Its high tolerance and lytic activity indicated that R21Y may be a candidate for phage therapy in controlling vibriosis in aquacultural systems.
Keyphrases
- pseudomonas aeruginosa
- biofilm formation
- multidrug resistant
- infectious diseases
- photodynamic therapy
- acinetobacter baumannii
- escherichia coli
- cystic fibrosis
- single molecule
- genome wide
- risk assessment
- high resolution
- optic nerve
- drug resistant
- risk factors
- cardiovascular disease
- gene expression
- cardiovascular events
- circulating tumor
- copy number
- high throughput
- dna methylation
- human health
- coronary artery disease
- type diabetes
- cell free
- binding protein
- genetic diversity
- nucleic acid
- molecularly imprinted
- climate change
- disease virus